Wisconsin Fertility Institute clinic ranked among America's Best Fertility Clinics for 2025.
PorAinvest
lunes, 16 de junio de 2025, 9:04 am ET1 min de lectura
IVF--
The ranking, prepared by Newsweek in partnership with Statista, lists the top facilities defined as a fertility clinic and advanced reproductive technologies (ART) provider by the Centers for Disease Control and Prevention (CDC). The evaluation was based on four criteria: quality metrics from the CDC, a nationwide online survey of reproductive endocrinologists, infertility specialists, obstetricians/gynecologists, and other medical professionals, accreditation data from The Joint Commission (JCI), College of American Pathologists (CAP), Clinical Laboratory Improvement Amendments (CLIA), and American Institute of Ultrasound in Medicine (AIUM), and patient satisfaction data based on Google reviews.
“We are thrilled and honored that Wisconsin Fertility Institute has been recognized as one of America’s Best Fertility Clinics by Newsweek in 2025,” commented Steve Shum, CEO of INVO Fertility. “This accolade reflects the unwavering dedication of our exceptional team in delivering compassionate, high-quality fertility care.”
INVO Fertility is dedicated to expanding assisted reproductive technology (ART) care to patients in need. The company's principal commercial strategy includes building, acquiring, and operating fertility clinics, including “INVO Centers” dedicated to offering the intravaginal culture (IVC) procedure enabled by the proprietary INVOcell® medical device. The IVC procedure provides patients with a more natural, intimate, and affordable experience compared to other ART treatments [2].
The INVOcell is the first medical device to allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure is believed to deliver comparable results at a fraction of the cost of traditional IVF and is considered significantly more effective than intrauterine insemination (IUI).
For more information about Wisconsin Fertility Institute’s services or to schedule a consultation, visit [Wisconsin Fertility Institute](https://wisconsinfertility.com/) or contact the team at 608-824-0075.
References:
[1] https://www.marketscreener.com/quote/stock/INVO-FERTILITY-INC-10622044/news/INVO-Fertility-s-Wisconsin-Clinic-Recognized-on-Newsweek-s-List-of-America-s-Best-Fertility-Cl-50251252/
[2] https://www.globenewswire.com/news-release/2025/06/16/3099867/0/en/INVO-Fertility-s-Wisconsin-Clinic-Recognized-on-Newsweek-s-List-of-America-s-Best-Fertility-Clinics-for-2025.html
INVO Fertility's Wisconsin Fertility Institute clinic has been named to Newsweek's list of America's Best Fertility Clinics for 2025. The ranking was based on four criteria, including quality metrics from the CDC and a nationwide online survey of reproductive endocrinologists and infertility specialists.
MIDDLETON, Wis. and SARASOTA, Fla. — INVO Fertility, Inc. (Nasdaq: IVF), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics, announced today that its Wisconsin Fertility Institute clinic has been included on Newsweek’s list of America’s Best Fertility Clinics for 2025 [1].The ranking, prepared by Newsweek in partnership with Statista, lists the top facilities defined as a fertility clinic and advanced reproductive technologies (ART) provider by the Centers for Disease Control and Prevention (CDC). The evaluation was based on four criteria: quality metrics from the CDC, a nationwide online survey of reproductive endocrinologists, infertility specialists, obstetricians/gynecologists, and other medical professionals, accreditation data from The Joint Commission (JCI), College of American Pathologists (CAP), Clinical Laboratory Improvement Amendments (CLIA), and American Institute of Ultrasound in Medicine (AIUM), and patient satisfaction data based on Google reviews.
“We are thrilled and honored that Wisconsin Fertility Institute has been recognized as one of America’s Best Fertility Clinics by Newsweek in 2025,” commented Steve Shum, CEO of INVO Fertility. “This accolade reflects the unwavering dedication of our exceptional team in delivering compassionate, high-quality fertility care.”
INVO Fertility is dedicated to expanding assisted reproductive technology (ART) care to patients in need. The company's principal commercial strategy includes building, acquiring, and operating fertility clinics, including “INVO Centers” dedicated to offering the intravaginal culture (IVC) procedure enabled by the proprietary INVOcell® medical device. The IVC procedure provides patients with a more natural, intimate, and affordable experience compared to other ART treatments [2].
The INVOcell is the first medical device to allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure is believed to deliver comparable results at a fraction of the cost of traditional IVF and is considered significantly more effective than intrauterine insemination (IUI).
For more information about Wisconsin Fertility Institute’s services or to schedule a consultation, visit [Wisconsin Fertility Institute](https://wisconsinfertility.com/) or contact the team at 608-824-0075.
References:
[1] https://www.marketscreener.com/quote/stock/INVO-FERTILITY-INC-10622044/news/INVO-Fertility-s-Wisconsin-Clinic-Recognized-on-Newsweek-s-List-of-America-s-Best-Fertility-Cl-50251252/
[2] https://www.globenewswire.com/news-release/2025/06/16/3099867/0/en/INVO-Fertility-s-Wisconsin-Clinic-Recognized-on-Newsweek-s-List-of-America-s-Best-Fertility-Clinics-for-2025.html
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios